IN 1920 Dr. E. A. Codman, of Boston, organized the Registry of Bone Sarcoma. A committee consisting of Dr. Codman, Dr. Ewing and Dr. Bloodgood studied a large number of cases of bone tumors, and from ...

Giant cell granuloma and its related lesions constitute a diverse group of benign yet potentially aggressive osseous entities that primarily affect the craniofacial region. These lesions are typically ...

Daiichi Sankyo has received approval for its treatment for the rare joint tumor. The FDA has given the nod to pexidartinib (Turalio), marking the first approved treatment for adult patients with ...

A systematic analysis demonstrated the rarity of super-giant basal cell carcinomas and the need for further characterization of these understudied skin cancers. Super-giant basal cell carcinoma (SGBCC ...

Trends in real-world clinical outcomes among patients (pts) with metastatic pancreatic adenocarcinoma (mPDAC) treated with liposomal irinotecan based regimens in the United States (US). This is an ...

Tenosynovial giant cell tumors are not malignant but can impact patients’ quality of life, as one expert explained. There are not many patients with tenosynovial giant cell tumors, or TGCTs, with one ...

These findings suggest that LIS is a reliable predictive tool for clinically relevant outcomes and response to denosumab therapy in patients with GCTB. These parameters may prove to be useful in ...

Dr. Austin Be (Surgery): A 14-year-old girl was admitted to this hospital because of swelling of the left jaw. The patient had been well until 6 weeks before this admission, when she noticed a lump in ...

EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced the presentation of detailed positive results from Part 1 of the global Phase 3 MANEUVER ...

Today, the U.S. Food and Drug Administration granted approval to Turalio (pexidartinib) capsules for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) associated ...